Around 10% of patients with AML have mutations in splicing factors, such as SRSF2, U2AF1, SF3B1, and ZRSR2. These patients tend to be older and have less proliferative disease. These mutations are believed to cause the missplicing of genes involved in epigenetic regulation, transcription, and genome integrity.